The total value of deals announced for the year is now $4.6 trillion, ahead of the $4.3 trillion recorded for 2007. Big deals include Pfizer/Allergan in pharma and ABInBev/SABMiller in brewing.
Scott Barshay of Cravath, Swaine & Moore has worked on deals worth over $250 billion this year. He said: 'It doesn’t feel like we are in bubble territory yet because the transactions you’re seeing have industrial logic. Momentum on strategic deals is strong ... it feels like 2016 is going to look a lot like 2015.' Source: Financial Times